IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
225.85
+0.93 (0.41%)
Dec 5, 2025, 4:00 PM EST - Market closed
IQVIA Holdings Market Cap
IQVIA Holdings has a market cap or net worth of $38.46 billion as of December 5, 2025. Its market cap has increased by 10.93% in one year.
Market Cap
38.46B
Enterprise Value
51.73B
1-Year Change
10.93%
Ranking
Category
Stock Price
$225.85
Market Cap Chart
Since May 9, 2013, IQVIA Holdings's market cap has increased from $5.46B to $38.46B, an increase of 604.73%. That is a compound annual growth rate of 16.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 38.24B | 7.21% |
| Dec 31, 2024 | 35.67B | -15.54% |
| Dec 29, 2023 | 42.23B | 10.96% |
| Dec 30, 2022 | 38.06B | -29.39% |
| Dec 31, 2021 | 53.90B | 56.91% |
| Dec 31, 2020 | 34.35B | 14.58% |
| Dec 31, 2019 | 29.98B | 27.57% |
| Dec 31, 2018 | 23.50B | 13.60% |
| Dec 29, 2017 | 20.69B | 10.50% |
| Dec 30, 2016 | 18.72B | 121.52% |
| Dec 31, 2015 | 8.45B | 12.33% |
| Dec 31, 2014 | 7.52B | 25.93% |
| Dec 31, 2013 | 5.97B | 9.47% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |